Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors
Title:
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors
Author:
Ochsenreither, S. Fiedler, W.M. Conte, G.D. Macchini, M. Matos, I. Habel, B. Ahrens-Fath, I. Raspagliesi, F. Lorusso, D. Keilholz, U. Rolling, C. Kebenko, M. Klinghammer, K.F. Saavedra, O. Baumeister, H. Zurlo, A. Garralda, E.